What is the dosage and frequency of diphenhydramine (antihistamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diphenhydramine Dosing and Frequency

For adults, administer diphenhydramine 25-50 mg every 4-6 hours (maximum 6 doses per 24 hours), and for children, use 1-2 mg/kg per dose every 4-6 hours with a maximum single dose of 50 mg. 1, 2, 3

Adult Dosing

  • Standard dose: 25-50 mg per dose administered orally or parenterally every 4-6 hours, with a maximum of 6 doses in 24 hours 1, 3
  • For allergic reactions requiring parenteral administration, use 25-50 mg intramuscularly or intravenously 1, 2
  • When used for sedation as a procedural adjunct, administer 25-50 mg intravenously 1
  • For discharge therapy following allergic reactions, prescribe diphenhydramine every 6 hours for 2-3 days 1

Important Administration Considerations for Adults

  • Intravenous administration must be given slowly to minimize adverse effects including hypotension and dizziness 1
  • Parenteral routes provide faster onset of action (several minutes) compared to oral administration 1, 2
  • Duration of effect is 4-6 hours regardless of route 1, 2

Pediatric Dosing

  • Weight-based dosing: 1-2 mg/kg per dose every 4-6 hours 1, 2
  • Maximum single dose: 50 mg regardless of calculated weight-based dose 1, 2
  • Children 6 to under 12 years: 10 mL (25 mg) every 4-6 hours, maximum 6 doses per 24 hours 3
  • Children under 6 years: FDA labeling states "do not use" for over-the-counter products 3

Pediatric Pharmacokinetic Considerations

  • Children have significantly faster clearance rates (49.2 mL/min/kg) and shorter elimination half-lives (5.4 hours) compared to adults, which supports the every 4-6 hour dosing interval 4

Route-Specific Guidance

  • For anaphylaxis: Parenteral administration (IM or IV) is preferred for faster onset, but diphenhydramine is always second-line to epinephrine and should never be administered alone 1, 2
  • Oral administration: Appropriate for mild allergic reactions, urticaria, and maintenance therapy 3
  • Intravenous administration: Reserved for acute severe reactions or procedural sedation, must be given slowly 1

Clinical Algorithm for Allergic Reactions

  1. First-line: Administer epinephrine for anaphylactic reactions 2
  2. Adjunctive therapy: Give diphenhydramine 25-50 mg IM (adults) or 1-2 mg/kg IM (children, max 50 mg) 2
  3. Consider adding: H2-antagonist such as ranitidine, as the combination is superior to diphenhydramine alone for urticaria 2
  4. Corticosteroids: Administer hydrocortisone 200 mg IV for adults to prevent biphasic reactions 2

Critical Safety Warnings

  • Never replace epinephrine with diphenhydramine as first-line treatment for anaphylaxis 2
  • Common adverse effects include dizziness, blurred vision, dry mouth, hypotension, urinary retention, and wheezing 1
  • Hypnotic effects are significantly increased when combined with alcohol, benzodiazepines, or opioid narcotics 1
  • Elderly adults have prolonged elimination half-lives (13.5 hours) and reduced clearance, increasing risk of adverse effects 4
  • Recent evidence suggests diphenhydramine has a problematic therapeutic ratio with higher adverse effects in children and older adults, leading some countries to restrict access 5

Special Populations

  • Elderly adults: Consider dose reduction due to significantly prolonged half-life (13.5 hours vs 9.2 hours in young adults) and reduced clearance 4
  • Toxic ingestions: Children under 6 years ingesting ≥7.5 mg/kg, or patients ≥6 years ingesting ≥7.5 mg/kg or 300 mg (whichever is less) require emergency department evaluation 6

References

Guideline

Diphenhydramine Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diphenhydramine IM Dosing for Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diphenhydramine: It is time to say a final goodbye.

The World Allergy Organization journal, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.